252 related articles for article (PubMed ID: 36544679)
1. Multi-omics profiling identifies C1QA/B
Zheng F; Zhang W; Yang B; Chen M
Ann Transl Med; 2022 Nov; 10(22):1249. PubMed ID: 36544679
[TBL] [Abstract][Full Text] [Related]
2. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
4. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
[TBL] [Abstract][Full Text] [Related]
5. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Zhang J; Dong Y; Di S; Xie S; Fan B; Gong T
Biomed Pharmacother; 2023 Nov; 167():115610. PubMed ID: 37783153
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients.
Zhang S; Zhang S; Ma X; Zhan J; Pan C; Zhang H; Xie X; Wen J; Xie X
Front Cell Infect Microbiol; 2023; 13():1165790. PubMed ID: 37180444
[TBL] [Abstract][Full Text] [Related]
7. A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis.
Shi Q; Liu M; Wang S; Ding P; Wang Y
J Thorac Dis; 2023 Mar; 15(3):1387-1397. PubMed ID: 37065557
[TBL] [Abstract][Full Text] [Related]
8. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
9. A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma.
Liu F; Yuan D; Liu X; Zhuo S; Liu X; Sheng H; Sha M; Ye J; Yu H
Discov Oncol; 2023 Jun; 14(1):96. PubMed ID: 37306828
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
11. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review.
Chabeli MS; Wang X; Yinghao L; Chen C; Yang C; Shou Y; Wang S; Chen K
Cancer Treat Res Commun; 2022; 32():100621. PubMed ID: 36007473
[TBL] [Abstract][Full Text] [Related]
12. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma.
Guo W; Zhou B; Yang Z; Liu X; Huai Q; Guo L; Xue X; Tan F; Li Y; Xue Q; Gao S; He J
EBioMedicine; 2022 Oct; 84():104281. PubMed ID: 36162205
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
[TBL] [Abstract][Full Text] [Related]
14. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.
Li R; Huang B; Tian H; Sun Z
Front Oncol; 2022; 12():1096717. PubMed ID: 36698392
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma.
Huang Q; Chen H; Yin D; Wang J; Wang S; Yang F; Li J; Mu T; Li J; Zhao J; Yin R; Li W; Qiu M; Zhang E; Li X
NPJ Precis Oncol; 2024 Jan; 8(1):24. PubMed ID: 38291241
[TBL] [Abstract][Full Text] [Related]
17. Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma.
Bian Y; Bi G; Shan G; Liang J; Yao G; Sui Q; Hu Z; Zhan C; Chen Z; Wang Q
Heliyon; 2023 Aug; 9(8):e18132. PubMed ID: 37529341
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
[No Abstract] [Full Text] [Related]
19. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
20. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
